. The clinical and histological staging of the disease in relation to the survival time is evaluated. The variation in the clinical patterns of the disease, together with the histological appearances in the affected glands, can be related to the patient's defence system. A most important clinical factor in assessing prognosis is considered to be the presence or absence of constitutional symptoms. The majority of the patients who had constitutional symptoms on presentation also had many glands involved. It was found in those patients who had no constitutional symptoms at the onset of the disease that there was little difference in survival time between those with glands involved in a single group or region and those with glands involved in many regions, whether above and/or below the diaphragm. Those patients with histologically well differentiated lesions showed a significantly higher survival rate than those in the histologically poorly differentiated groups.
Previous assessments of the prognosis of Hodgkin's disease have concentrated on two main factors, histological findings and clinical presentation.
Histological Assessment
Jackson and Parker (1944) separated Hodgkin's disease into paragranuloma, granuloma, and sarcoma. This showed reasonable agreement in that the cases of paragranuloma had a long survival and those of sarcoma a short one, but the prognostic value of the classification was somewhat limited, as the combined paragranuloma and sarcoma cases, on average, failed to represent more than 10 % of the cases of Hodgkin's disease, whilst in the remainder, classified as granuloma, patients lived from one to 20 years. Lukes and Butler (1966) divided Hodgkin's disease into six types: lymphocytic and/or histiocytic diffuse, lymphocytic and/or histiocytic nodular, nodular sclerosis, mixed cellularity, diffuse fibrosis, and reticular types. They claimed a definite relationship between the different histological types and survival time.
At a symposium on the obstacles to the control of Hodgkin's disease in New York (1965) a new classification, based on that of Lukes and Butler, divided Hodgkin's disease into four groups: lymReceived for publication 30 September 1970. phocytic predominance, nodular sclerosis, mixed cellularity, and lymphocytic depletion.
Using a classification based on different histological criteria, Cross (1969) claimed an excellent correlation between the histologically determined types and survival time. The basis of the classification was the division of Hodgkin's disease into three groups, namely, reticular, histiocytic, and nodular sclerosis, depending on the presence or absence of epithelioid histiocytes or nodular formation of the fibrous tissue. Each group was subclassified into well and poorly differentiated types. Survival figures showed that the well differentiated types in each group had a good prognosis, whereas the poorly differentiated types had a bad one.
Cliniical Assessment Peters (1950) considered that 'although the histological picture was necessary for proof of diagnosis, it acted as an aid only in establishing the prognosis, but it was not as conclusive as the clinical findings demonstrated by the extent of lymph node involvement at first presentation'. She produced a clinical classification which divided Hodgkin's disease into three stages (Table I) . Peters and Middlemiss (1958) Table I Clinical classification according to extent of involvement on admission (Peters, 1950) symptoms in stage II. They concluded that the most important single factor influencing the prognosis and ultimate survival time of a case of Hodgkin's disease was the extent of lymph gland involvement when treatment was begun. The necessity for a standardized classification was once more emphasized at the Rye symposium (1965) . The following clinical criteria for staging Hogdkin's disease were agreed to by the committee and approved by the members of that conference (Table II) . We now propose to attempt to relate the various clinically definable patterns to the histologically determined diagnosis as already described (Cross, 1969) . Thus, we found that patients who lived for eight or more years showed the histological patterns of reticular lymphocytic (paragranuloma), well differentiated histiocytic, and well differentiated nodular sclerosis types. The last two, for convenience, were grouped together. Long-term survivors (as defined above) were found to have a variety of histologically assessed lesions.
Reticular lymphocytic (paragranuloma) Patients with this type of lesion presented with slow, painless enlargement of a single anatomical region, usually the neck, with involvement of one or several glands, but other areas, such as the axilla or inguinal region, could be involved. Following a diagnostic biopsy the treatment was generally radiotherapy, and the patient remained free from symptoms for many years. With recurrences, biopsy again showed, in most cases, a similar histological appearance. Eventually, however, in the majority over eight years, the disease changed clinically and further histological examination of a lymph gland showed a well differentiated reticular type of lesion; death then followed within four years. Occasionally, even in the first relapse, the biopsied nodes showed, histologically, features previously defined (Cross, 1969) as typical of a poorly differentiated reticular type of lesion; in such cases, survival time was usually much shorter. It is possible that change to this type of pattern may account for some of the acute cases which gave a history of glandular enlargement many years before but in whom no biopsy had been carried out.
Well differentiated histiocytic and nodular sclerosis types In general, these patients showed slow clinical progression and only one had constitutional symptoms at the onset. In patients with such slow and insidious onset, many presented initially with multiple gland involvement. Thus, of 44 patients with histological lesions considered to be of the histiocytic and nodular sclerosis groups, 31 (70%) had many glands involved on presentation. The course of the illness in these patients was characteristic. Given appropriate treatment, usually radiotherapy, they remained well for about two years and then relapsed, either at the original site or elsewhere. Treatment of recurrences of glandular swelling was satisfactory and they were reasonably fit to carry on with their occupations. Recurrence and good response to therapy, in many cases every two years, went on for many years, usually more than eight, until finally they died from multiple lesions with involvement of the spine, intercurrent infections, and histological appearances suggesting obliteration of the normal reticulo-endothelial system.
In agreement with Lukes' (1963) and Hanson's (1964) findings, the frequency of mediastinal involvement in the nodular sclerosis cases was high (Table III) . The incidence of mediastinal involvement on initial presentation in the well differentiated nodular sclerosis cases was about four times that of mediastinal involvement in the rest of the well differentiated types as a whole. This incidence was also higher than that of the patients who presented with constitutional symptoms in both well differentiated and poorly differentiated types other than nodular sclerosis. There appears, thus, to be a high predilection for mediastinal involvement in patients with the nodular sclerosis type of lesion. The reason for this is unknown. Patients with a short survival time Most of the patients who behaved in this manner were shown to have, on biopsy of the lymph glands, poorly differentiated types of all groups. The majority of these patients presented with constitutional symptoms. In 109 patients, in whom the initial histological diagnosis was of the poorly differentiated reticular, histiocytic, and nodular sclerosis groups, 81 (74%) had constitutional symptoms at the onset. The disease seemed to be so sudden in onset and so progressive, that, by the time the patient first consulted the doctor, he was most likely to have enlarged glands widespread throughout the body. If only one gland or region was involved at presentation but was histologically diagnosed as poorly differentiated, then involvement of many glands usually soon followed within three months. Irrespective of the type of therapy used, immediate response was frequently dramatic. However, despite such excellent response to initial treatment, relapse soon occurred and, in general, death took place within four years and often under two years. Thus, our combined clinical and histological study indicated that a histopathological diagnosis of poorly differentiated reticular, histiocytic, or nodular sclerosis types of lesion carried with it a very bad prognosis.
Assessment of Survival Time
CLINICAL ASSESSMENT ALONE Peters and Middlemiss (1958) stated that the 'survival rates and the incidence of recurrences reveal that there is at least a 35% error in clinical staging'. This was before the use of lymphangiography. With more experience regarding occult disease, Peters (1968) considered that out of 53 patients, who were classified as either stage I, IIA, or IIB, specialized procedures, such as lymphography, intravenous pyelograms, inferior venocavograms, bone marrow histology, and liver scan, showed that 29 (55 %) were wrongly classified.
All the patients in the present series were reviewed clinically within one month after presentation by two consultant surgeons, and only their assessment of the clinical findings were accepted.
For the purpose of estimating the survival times, 246 patients were available for the two-year assessment: 217 for the five years, 166 for the 10 years, and 121 for the 15 years. The distribution of our series of patients and the number of two, 10-, and 15-year survivors were classified according to the method of Peters and Middlemiss (1958) as seen in Table IV . It would appear from Table IV (Table V) compares the Halton series with those of Peters (1950) , Peters and Middlemiss (1958) , and Lukes (1963) . Although the five-year survival times in the stage I and II groups in our series are not as high as those reported by Peters (1950 and 1958) and Lukes (1963) In planning treatment, the important factors are: the presence or absence of constitutional symptoms; the extent of the disease; the histological grading, which is also considered to provide some indication of the host resistance.
In general, the treatment of Hodgkin's disease includes surgery, radiotherapy, and cytotoxic drugs.
Surgical Therapy
Molander and Pack (1968) considered that radical excision of affected and related nodes may be the initial treatment of choice in clearly defined unifocal Hodgkin's disease, although only in a few selected patients. In the present series, however, radical surgery was not attempted in any patient as primary treatment.
Radiotherapy
Radiotherapy was the initial form of treatment for most of our patients. However, in recent years it has been our practice to treat those presenting with severe constitutional symptoms in the first instance with cytotoxins. Treatment by radiotherapy to the initial site or sites alone was practised until the late 1950s after which time those patients who presented with involvement of one or both sides of the neck were given in addition prophylactic irradiation to the mediastinum. In general, the patients with paragranuloma involving cervical nodes had initial deep x-ray therapy to these sites alone.
Although Peters (1958) stated that the radiotherapist was not anxious to irradiate more normal tissue than was necessary, Kaplan and Rosenberg (1966) and Peters (1968) advised that the 'extended field method of radical radiotherapy be carried out in all patients with Hodgkin's disease'. This entailed giving a tumoricidal dose of irradiation to the whole lymphatic area whether above or below the diaphragm if the patient had stage I or II disease (Peters and Middlemiss or Rye classification). Kaplan and Rosenberg (1966) and Peters (1968) claimed an improvement in survival rate with such extended irradiation schedules. However, the figures quoted refer to comparisons of survival times of patients classified by clinical staging alone and not by clinical and histological methods of grading the disease at the onset.
Chemotherapy
In this series, the drugs used have been Degranol (mannomustine), HN2 (nitrogen mustard), Velbe, Leukeran, Cyclophosphamide, and Natulan (methyl hydrazine). In those patients, in our series, presenting without constitutional symptoms the histological grading was, in the majority, either paragranuloma or the well differentiated reticular, histiocytic, or nodular sclerosis type previously described (Cross, 1969) . Initially, treatment was by radiotherapy, but, in the event ofrecurrence of the disease at the original site or sites, consideration was given to further irradiation and/or cytotoxic therapy. In the patients with severe constitutional symptoms on presentation, the majority were histologically poorly differentiated. This group consisted, on the whole, of patients who were acutely ill and they were treated initially with cytotoxic drugs only. Our practice has been to give nitrogen mustard to a total dose of 20-30 mg of HN.. If and when the constitutional symptoms resolved under such treatment, radiotherapy was considered.
In patients with recurrence of any histological type of the disease who had constitutional symptoms so severe as to be considered unfit for radiotherapy, it was decided to avoid, when possible, long periods of maintenance therapy with cytotoxic drugs, because of the probable further damage to the reticuloendothelial system. Instead, short-term, but massive therapy with cyclophosphamide was given. By this is meant the administration of 5 g given over a period of five to six days together with, when necessary, barrier nursing (Binns and Southall, 1970 (Rappaport and Strum, 1970) , when the limiting factor to metastatic foci would be the immune process. As the disease progressed the gradual elimination of the immune defences could be expected through destruction of the reticuloendothelial system. This may well account for the frequent findings at necropsy of multiple foci of Hodgkin's disease scattered throughout the body. Lukes, Butler, and Hicks (1966) indicated that prolonged survival in Hodgkin's disease was associated with histological types manifested by lymphocytic proliferation, and this association emphasized again the importance of the lymphocyte in prognosis presented by Rosenthal (1936) . These views on the importance of lymphocytic proliferation in the prognosis of Hodgkin's disease was shown in the better survival times of patients with well differentiated histological types of lesions in the involved lymph nodes (Cross, 1969 
